Local Links Curriculum Vitae Professional Web page  Talks Awards

 Professional Organizations

American Statistical Association   International Biometric Society (East-North American Region) (West-North American Region) (East-Mediterranean Region)   International Society for Bayesian Analysis   Institute of Mathematical Statistics   American Association for the Advancement of Science

 

Collaborative Scientific/Medical Publications

 

2006

 

1. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM,     Lippman SM, Shureiqi I. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. Feb 23;25(8):1225-41, 2006.

 

2005

1. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, and Lippman SM.  Critical role of 15-Lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.  Cancer Research, 65(24): 11486-92, 2005.

2. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, and Shureiqi I.  Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.  Oncogene, 25(8): 1225-41, 2005.

3. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris JS, Liao Z, Komaki R, and Ajani JA: Value of baseline positron emission tomography for predicting overall survival in patients with non-metastatic esophageal or gastroesophageal junction carcinoma.  Cancer, 104(8): 1620-1626, 2005.

4.  Beach R, Chan AOO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, and Rashid A (2005). BRAF mutations in aberrant crypt foci and hyperplastic polyposis. The American Journal of Pathology, 166(4), 1069-1075.

5.  Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, and Wu TT (2005). Posttherapy pathological stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.  Cancer, 103(7), 1347-1355.

6.   Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris JS, and Pisters PW (2005).   Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome.  Journal of Clinical Oncology, 23(6), 1237-1244.

7. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN (2005). Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. Journal of Vascular and Interventional Radiology, 2(1): 215-225.

2004

1. Ajani JA, Mansfield PF, Janjan N, Morris JS, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, and Gunderson LL (2004). A multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.  Journal of Clinical Oncology 22(14), 2774-2780

2.  Ajani J, Walsch G, Komaki RR, Morris JS, Swisher SG, Lynch P, Wu TT, Vaporciyan A, Faust JC, Nivers RJ, and Roth J (2004). Preoperative induction CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with local-regional carcinoma of the esophagus or gastroesophageal junction.  Cancer 100(11): 2347-2354.

3. Sinicrope FA, Half E., Morris JS, Lynch PM, Morrow JD, Levin B, Steinbach G, Hawk ET, Cohen DS, Ayers GD, Stephens LC, FAP Study Group (2004). Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in Familial Adenomatous Polyposis (FAP) patients. Cancer Epidemiology, Biomarkers, and Prevention, 13(6): 1-8.

2003

1.   Pawlik TM, Izzo F, Cohen DS, Morris JS, and Curley SA (2003). Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients.  Journal of Surgical Oncology 10(9): 1059-1069.

2.  Pawlik TM, Paulino AF, Mcginn CJ, Baker LH, Cohen DS, Morris JS, Rees R, and Sondak VK (2003). Cutaneous angiosarcoma of the scalp: A multidisciplinary approach.  Cancer 98(8): 1716-1726.

3.  Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM (2003). The 15-lipoxygenase-1 product 13-S-hydroxyocta-decadienoic acid down-regulates PPAR-{delta} to induce apoptosis in colorectal cancer cells. Proceedings of the National Academy of Sciences 100(17): 9968-9973.

4. Hong MY, Chapkin RS, Davidson LA, Turner ND, Morris JS, Carroll RJ, and Lupton JR (2003). Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating BCL-2.  Nutrition and Cancer 46(1): 44-51.

5. Switzer KC, McMurray DN, Morris, JS and Chapkin RS (2003). N-3 polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes.  The Journal of Nutrition 133 (2):  496-503.

6. Madoff DC, Hicks ME, Abdalla EK, Morris JS and Vauthey JN (2003).  Portal vein embolization using polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy:  Safety and Efficacy:  A study in 26 patients.  Radiology 227(1): 251-260.

7. Lin E, Morris JS, and Ayers GD (2003)  Effect of Celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity.  Oncology 16 (12 supplement No 14): 31-37.

2002
 

1. Chan AOO, Issa-J-PJ, Morris JS, Hamilton SR and Rashid A (2002).  Concordant CpG Island Methylation in Hyperplastic Polyposis.  The American Journal of Pathology 160: 529-536.

2001

1. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM and Lippman SM (2001).  Nonsteroidal Anti-inflammatory Drugs Induce Apoptosis in Esophageal Cancer Cells by Restoring 15-Lipoxygenase-1 Expression.  Cancer Research 61: 4879-4884.

2. Arrington JL, Chapkin RS, Switzer KC, Morris JS and McMurray DN (2001).  Dietary n-3 Polyunsaturated Fatty Acids Modulate Purified Murine T-cell Subset Activation.  Clinical and Experimental Immunology 125: 499-507.

3.  Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, Turner ND, Chang WCL, Davidson FA and Lupton JR (2001).  Anatomical Site-Specific Response to DNA Damage is Related to Later Tumor Development in the Rat AOM Colon Carcinogenesis Model.   Carcinogenesis 22:1831-1835.

4.  Shureiqi I, Cook CD, Morris JS, Soliman AS, Levin B, and Lippman SM (2001). Effect of Age on Risk of Second Primary Colorectal Cancer.  Journal of the National Cancer Institute 93: 1264-1265.

5. Rashid A, Lanlan S, Morris JS, Issa J-PJ, Hamilton SR (2001). CpG island methylation in colorectal adenomas. The American Journal of Pathology 159:1129-1135.

 

2000

 

1. Davidson LA, Brown RE, Chang W-CL, Lupton JR, Morris JS, Wang N, Carroll, RJ, Turner, ND and Chapkin, RS (2000) Morphodensitometric Analysis of Protein Kinase C b_II Expression in the Rat Colon:  Modulation by Diet and Relation to in situ Cell Proliferation and Apoptosis.  Carcinogenesis 21: 1513-1519.

2. Hong MY, Lupton JR, Morris JS, Wang N, Carroll RJ, Davidson LA, Elder R and Chapkin RS (2000).  Dietary Fish Oil Reduces 0⁶-methylguanine DNA Adduct Levels in the Rat Colon In Part By Increasing Apoptosis During Tumor Initiation.  Cancer Epidemiology, Biomarkers and Prevention 9: 819-826.

 

1999

 

1. Hong MY, Chapkin RS, Wild CP, Morris JS, Wang N, Carroll RJ, Turner ND and Lupton JR (1999)  Relationship Between DNA Adduct Levels, Repair Enzyme and Apoptosis as a Function of DNA Alkylation by Azoxymethane.  Cell Growth and Differentiation 10: 749-758.